Earlier this month, there were reports that the third phase of clinical trials of a dengue vaccine candidate will soon start across the country. PREMIUM (Representational Image) According to the company, the clinical studies showed the vaccine to be safe and well tolerated (AFP) One of the Indian Council of Medical Research (ICMR) research institutes, …
The United States Agency for International Development (USAID) and Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Private Limited) have launched a new campaign called “Haarega Dengue Haraenge Hum (We Will Together Defeat Dengue).” With changing climate conditions threatening lives, health, economic progress, and straining resilience particularly among the most vulnerable, the campaign in launch phase …
Japanese pharmaceutical company, Takeda, on Tuesday announced a strategic partnership with Biological E. Limited, Hyderabad based leading vaccines and biologics company in India, to manufacture Takeda’s dengue vaccine, TAK-003. The partnership was announced on Tuesday at the Bo Asia conference. The partnership will substantially enhance manufacturing capabilities to ensure a sustainable global supply of the …
Takeda, a global biopharmaceutical company and Biological E. Limited (BE) on Tuesday announced a strategic partnership to accelerate access to Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003), multi-dose vials (MDVs). A press release from Takeda said these doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest …